Portland-based digital therapeutics startup MedRhythms Inc. is joining forces with Universal Music Group NV, the world’s largest music label, to bring “prescription music” to patients for the first time.
The partnership, announced Wednesday, will give MedRhythms access to nearly all of Universal’s catalog of millions of songs for the MedRhythms platform, which uses clinical sensors, software and music to help restore function lost to neurologic disease or injury.
“Since our product is based upon the neuroscience of music, and will be approved by the FDA as a prescription-only product, this means that the only way the product will be available to patients is through a prescription from a doctor,” Brian Harris, the company’s CEO and co-founder, told Mainebiz. “Once we receive FDA approval, we will be the world’s first prescription music platform.” Read more
